Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N, Mori K, Abe K, Dansako H, Kuroki M, Ariumi Y, Wakita T, IkedaM.
Virus Res., 146(1-2):41-50 (2009)
HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A.
Abe K, Ikeda M, Ariumi Y, D Hiromichi, Wakita T, Kato N.
Arch. Virol., 154(10):1671-77 (2009)
Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase.
Yano M, Ikeda M, Abe K, Kawai Y, Kuroki M, Mori K, Dansako H, Ariumi Y, Ohkoshi S, Aoyagi Y, Kato N.
Hepatology, 50(3):678-88 (2009)
Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-α.
Ikeda M, Mori K, Ariumi Y, Dansako H, Kato N.
FEBS Letters, 583(9) :1434-8(2009)
Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases.
Dansako H, Ikeda M, Ariumi Y, Wakita T,KatoN.
Arch. Virol., 154(5):801-10 (2009)
Development of an HCV relapse model using genome-length HCV RNA-harboring cells possessing the IFN-α-resistance phenotype.
Kawai Y, Ikeda M, Abe KI, Yano M, Ariumi Y, Dansako H, Yamamoto K, Kato N.
Hepatol. Res., 39(9):898-909 (2009)
Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress.
Kuroki M, Ariumi Y, Ikeda M, Dansako H, Wakita T, Kato N.
J. Virol., 83(5):2338-48 (2009)
Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents.
Nishimura G, Ikeda M, Mori K, Nakazawa T, Ariumi Y, Dansako H, Kato N.
Antiviral Res., 82(1): 42-50 (2009)
Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway.
Matsumoto A, Ichikawa T, Nakao K, Miyaaki H, Hirano K, Fujimito M, Akiyama M, Miuma S, Ozawa E, Shibata H, Takeshita S, Yamasaki H, Ikeda M, Kato N, Eguchi K.
J. Gastroenterol., 44(8): 856-63 (2009)
HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
Kasai D, Adachi T, Deng L, Nagano-Fujii M, Sada K, Ikeda M, Kato N, Ide YH, Shoji I, Hotta H.
J. Hepatol., 50(5):883-94 (2009)
Genetic variability and diversity of intracellular genome-length hepatitis C virus RNA in long-term cell culture.
Kato N, Abe K, Mori K, Ariumi Y, Dansako H, Ikeda M.
Arch. Virol., 154(1): 77-85 (2009)